659 related articles for article (PubMed ID: 23050473)
1. Protection from clinical disease against three highly virulent strains of Newcastle disease virus after in ovo application of an antibody-antigen complex vaccine in maternal antibody-positive chickens.
Kapczynski DR; Martin A; Haddad EE; King DJ
Avian Dis; 2012 Sep; 56(3):555-60. PubMed ID: 23050473
[TBL] [Abstract][Full Text] [Related]
2. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
Kapczynski DR; King DJ
Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
[TBL] [Abstract][Full Text] [Related]
3. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
[TBL] [Abstract][Full Text] [Related]
4. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
[TBL] [Abstract][Full Text] [Related]
5. Effect of phylogenetic diversity of velogenic Newcastle disease virus challenge on virus shedding post homologous and heterologous DNA vaccination in chickens.
Mohamed MH; Abdelaziz AM; Kumar S; Al-Habib MA; Megahed MM
Avian Pathol; 2016; 45(2):228-34. PubMed ID: 26813237
[TBL] [Abstract][Full Text] [Related]
6. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
Miller PJ; King DJ; Afonso CL; Suarez DL
Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
[TBL] [Abstract][Full Text] [Related]
7. Comparison of viral shedding following vaccination with inactivated and live Newcastle disease vaccines formulated with wild-type and recombinant viruses.
Miller PJ; Estevez C; Yu Q; Suarez DL; King DJ
Avian Dis; 2009 Mar; 53(1):39-49. PubMed ID: 19432002
[TBL] [Abstract][Full Text] [Related]
8. Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels.
Sarfati-Mizrahi D; Lozano-Dubernard B; Soto-Priante E; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
Avian Dis; 2010 Mar; 54(1 Suppl):239-41. PubMed ID: 20521638
[TBL] [Abstract][Full Text] [Related]
9. Characterization of live LaSota vaccine strain-induced protection in chickens upon early challenge with a virulent Newcastle disease virus of heterologous genotype.
Cornax I; Miller PJ; Afonso CL
Avian Dis; 2012 Sep; 56(3):464-70. PubMed ID: 23050461
[TBL] [Abstract][Full Text] [Related]
10. Novel in-ovo chimeric recombinant Newcastle disease vaccine protects against both Newcastle disease and infectious bursal disease.
Ge J; Wang X; Tian M; Wen Z; Feng Q; Qi X; Gao H; Wang X; Bu Z
Vaccine; 2014 Mar; 32(13):1514-21. PubMed ID: 24486349
[TBL] [Abstract][Full Text] [Related]
11. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
[TBL] [Abstract][Full Text] [Related]
12. In ovo vaccination of chicken embryos with experimental Newcastle disease and avian influenza oil-emulsion vaccines.
Stone H; Mitchell B; Brugh M
Avian Dis; 1997; 41(4):856-63. PubMed ID: 9454919
[TBL] [Abstract][Full Text] [Related]
13. Field trial in commercial broilers with a multivalent in ovo vaccine comprising a mixture of live viral vaccines against Marek's disease, infectious bursal disease, Newcastle disease, and fowl pox.
Sharma JM; Zhang Y; Jensen D; Rautenschlein S; Yeh HY
Avian Dis; 2002; 46(3):613-22. PubMed ID: 12243525
[TBL] [Abstract][Full Text] [Related]
14. Avian adeno-associated virus-based expression of Newcastle disease virus hemagglutinin-neuraminidase protein for poultry vaccination.
Perozo F; Villegas P; Estevez C; Alvarado IR; Purvis LB; Saume E
Avian Dis; 2008 Jun; 52(2):253-9. PubMed ID: 18646454
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a modified-live virus vaccine administered in ovo to protect chickens against Newcastle disease.
Ahmad J; Sharma JM
Am J Vet Res; 1992 Nov; 53(11):1999-2004. PubMed ID: 1466491
[TBL] [Abstract][Full Text] [Related]
16. In-ovo Newcastle disease virus vaccine strain TS09-C protects commercial chickens against Newcastle disease in the presence of maternally derived antibodies.
Fan S; Wu Y; Wang H; Shang Y; Luo Q; Zhang T; Zhang R; Zhang W; Luo L; Shao H; Wen G
Poult Sci; 2020 May; 99(5):2438-2443. PubMed ID: 32359578
[TBL] [Abstract][Full Text] [Related]
17. Development of a virosome vaccine for Newcastle disease virus.
Kapczynski DR; Tumpey TM
Avian Dis; 2003; 47(3):578-87. PubMed ID: 14562884
[TBL] [Abstract][Full Text] [Related]
18. Generation by reverse genetics of an effective, stable, live-attenuated newcastle disease virus vaccine based on a currently circulating, highly virulent Indonesian strain.
Xiao S; Nayak B; Samuel A; Paldurai A; Kanabagattebasavarajappa M; Prajitno TY; Bharoto EE; Collins PL; Samal SK
PLoS One; 2012; 7(12):e52751. PubMed ID: 23285174
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of an infectious bursal disease virus intermediate vaccine in ovo.
Coletti M; Del Rossi E; Franciosini MP; Passamonti F; Tacconi G; Marini C
Avian Dis; 2001; 45(4):1036-43. PubMed ID: 11785875
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of commercial inactivated Newcastle disease virus vaccines against Newcastle disease virus genotype VII in broiler chickens.
Sedeik ME; Elbestawy AR; El-Shall NA; Abd El-Hack ME; Saadeldin IM; Swelum AA
Poult Sci; 2019 May; 98(5):2000-2007. PubMed ID: 30561723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
